Froimson Mark

Pacira BioSciences, Inc. · Director

Froimson Mark is listed in filings as Director at Pacira BioSciences, Inc.. This profile follows SEC Form 4 activity through Jun 12, 2026, including purchase activity and sale activity. Recent filings connect the profile to Pacira BioSciences, Inc. (PCRX). The current snapshot covers public activity from Jun 13, 2024 to Jun 12, 2026. Reported amounts are shown as $255.1K to $16.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceLast Price
Pacira BioSciences IncPCRX$16k1.4k sharesBuyAug 12, 2024$11.58$25.38